Clinical Trials Browser

Phase 3 × Not yet recruiting × Epstein-Barr Virus Infections × Clear all

NCT05775705 2023-03-20

L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH

Phase 3 Not yet recruiting

LymphoidMyeloid

Lymphoma, Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic